<DOC>
	<DOCNO>NCT00430495</DOCNO>
	<brief_summary>This double-blind , placebo-controlled , parallel-arm , multicentre , prospective dose-finding trial safety efficacy atacicept subject active rheumatoid arthritis fail three month therapeutic trial tumor necrosis factor alpha ( TNFa ) antagonist due lack efficacy .</brief_summary>
	<brief_title>A Phase 2 Dose-finding Study Atacicept Subjects With Rheumatoid Arthritis ( AUGUST I )</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>1 . Rheumatoid arthritis ( RA ) satisfy American College Rheumatology ( ACR ) diagnostic criterion disease history least one year 2 . Male female great equal ( &gt; = ) 18years age time inform consent 3 . Active RA define : &gt; =8 swollen joint ( 66joint count ) , &gt; =8 tender joint ( 68joint count ) , Creactive protein ( CRP ) &gt; =10 milligram per liter ( mg/L ) ( central laboratory ) and/or erythrocyte sedimentation rate ( ESR ) &gt; = 28 millimeter per hour ( mm/h ) 4 . Failure least one TNFa antagonist therapy ( previously time screen ) specify protocol 5 . Other protocol define inclusion criterion could apply 1 . Any condition , include laboratory finding finding medical history pretrial assessment , opinion Investigator constitute risk contraindication subject 's participation trial could interfere trial objective , conduct evaluation 2 . Treatment biologics aim B cell modulation rituximab belimumab within 2 year study Day 1 3 . Any previous treatment anakinra ( Kineret ) , abatacept ( Orencia ) tocilizumab within 3 month study Day 1 4 . Use etanercept ( Enbrel ) within 28 day study Day 1 , infliximab ( Remicade ) adalimumab ( Humira ) within 60 day study Day 1 5 . Participation interventional clinical trial unapproved investigational therapy within 3 month start study ( within 5 halflives investigate compound study Day 1 , whichever long ) 6 . Other protocol define exclusion criterion could apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>atacicept</keyword>
	<keyword>arthritis</keyword>
</DOC>